Literature DB >> 28641776

The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies.

Gavin Giovannoni1, Chris Hawkes2, Emmanuelle Waubant3, Fred Lublin4.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28641776     DOI： 10.1016/j.msard.2017.06.005

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  3 in total

Review 1.  The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Authors:  Caterina Veroni; Francesca Aloisi
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 2.  Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates.

Authors:  Jihad S Inshasi; Sarmed Alfahad; Taoufik Alsaadi; Ali Hassan; Tayseer Zein; Victoria Ann Mifsud; Suzan Ibrahim Nouri; Mustafa Shakra; Ahmed Osman Shatila; Miklos Szolics; Mona Thakre; Ajit Kumar; Amir Boshra
Journal:  Neurol Ther       Date:  2021-04-23

3.  Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.

Authors:  Victor Gomez-Mayordomo; Paloma Montero-Escribano; Jordi A Matías-Guiu; Nuria González-García; Jesús Porta-Etessam; Jorge Matías-Guiu
Journal:  J Med Virol       Date:  2020-07-15       Impact factor: 20.693
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.